Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Ophthalmic Plastic and Reconstructive Surgery|October 22, 2019
Comparison of Orbital Volume in Young Versus Senescent Human SkullsKevin R Zhang, Brian H Chon, Catherine J Hwang, et al.
JAMA Ophthalmology|February 1, 2014
Effectiveness of intraocular pressure-lowering medication determined by washoutHenry D Jampel, Brian H Chon, Robert Stamper, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 20, 2019
Temporal Fat Pad Volume in Patients With Thyroid Eye DiseaseMaria M Choudhary, Kevin R Zhang, Scott Johnson, et al.
JAMA Ophthalmology|May 17, 2014
Single vs multiple intraocular pressure measurements in glaucoma surgical trialsMingjuan L Zhang, Brian H Chon, Jiangxia Wang, et al.
International Journal of Particle Therapy|October 23, 2020
Development of a Comprehensive, Contour-Based, Peer Review Workflow at a Community Proton CenterBenjamin T Cooper, Anuj Goenka, Kevin Sine, et al.
Aesthetic Plastic Surgery|December 1, 2020
Dimensions, Function and Applications of the Auricular Muscle in Facial Plastic SurgeryBrian H Chon, Alex D Blandford, Catherine J Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative GroupBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
International Journal of Particle Therapy|December 24, 2025
Feasibility and efficacy of hypofractionated proton reirradiation for recurrent lung cancerJerome M Karp, Kara M Banson, Oren Cahlon, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Cancer Research|January 4, 2008
Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cellsJames W Evans, Sophia B Chernikova, Lisa A Kachnic, et al.
Pageof 2